VERTEX PHARMACEUTICALS INC / MA Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for June 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Global Gov. St ... | Option Exercise | M | 33.82 | 20,000 | 676,400 | 10,500 | |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Global Gov. St ... | Option Exercise | M | 33.28 | 7,000 | 232,960 | 2,500 | |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Global Gov. St ... | Option Exercise | M | 33.55 | 15,250 | 511,638 | 0 | |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Global Gov. St ... | Sell | S | 98.03 | 42,250 | 4,141,768 | 38,671 | 80.9 K to 38.7 K (-52.21 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Global Gov. St ... | Buy | M | 33.82 | 20,000 | 676,400 | 80,921 | 60.9 K to 80.9 K (+32.83 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Global Gov. St ... | Buy | M | 33.28 | 7,000 | 232,960 | 60,921 | 53.9 K to 60.9 K (+12.98 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Global Gov. St ... | Buy | M | 33.55 | 15,250 | 511,638 | 53,921 | 38.7 K to 53.9 K (+39.44 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Riley Wayne Joseph | Director | Option Exercise | M | 33.89 | 15,000 | 508,350 | 5,000 | |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Riley Wayne Joseph | Director | Sell | S | 98.03 | 15,000 | 1,470,450 | 200 | 15.2 K to 200 (-98.68 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Riley Wayne Joseph | Director | Buy | M | 33.89 | 15,000 | 508,350 | 15,200 | 200 to 15.2 K (+7,500.00 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 38.80 | 5,234 | 203,079 | 3,516 | |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 37.29 | 7,500 | 279,675 | 0 | |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 98.03 | 12,734 | 1,248,314 | 23,350 | 36.1 K to 23.4 K (-35.29 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 38.80 | 5,234 | 203,079 | 36,084 | 30.9 K to 36.1 K (+16.97 %) |
| Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 37.29 | 7,500 | 279,675 | 30,850 | 23.4 K to 30.9 K (+32.12 %) |
| Jun 18 2014 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 32.16 | 7,500 | 241,200 | 15,500 | |
| Jun 18 2014 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 70.29 | 1,000 | 70,290 | 143,517 | 144.5 K to 143.5 K (-0.69 %) |
| Jun 18 2014 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 69.54 | 597 | 41,515 | 144,517 | 145.1 K to 144.5 K (-0.41 %) |
| Jun 18 2014 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 68.25 | 1,500 | 102,375 | 145,114 | 146.6 K to 145.1 K (-1.02 %) |
| Jun 18 2014 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 67.72 | 4,403 | 298,171 | 146,614 | 151 K to 146.6 K (-2.92 %) |
| Jun 18 2014 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 32.16 | 7,500 | 241,200 | 151,017 | 143.5 K to 151 K (+5.23 %) |
| Jun 11 2014 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Option Exercise | M | 34.32 | 2,500 | 85,800 | 15,000 | |
| Jun 11 2014 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Sell | S | 75.00 | 2,500 | 187,500 | 5,265 | 7.8 K to 5.3 K (-32.20 %) |
| Jun 11 2014 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Buy | M | 34.32 | 2,500 | 85,800 | 7,765 | 5.3 K to 7.8 K (+47.48 %) |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Option Exercise | A | 72.14 | 22,500 | 1,623,150 | 22,500 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | A | 72.14 | 20,000 | 1,442,800 | 20,000 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 72.14 | 22,500 | 1,623,150 | 22,500 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Riley Wayne Joseph | Director | Option Exercise | A | 72.14 | 20,000 | 1,442,800 | 20,000 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 72.14 | 20,000 | 1,442,800 | 20,000 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 72.14 | 20,000 | 1,442,800 | 20,000 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 72.14 | 20,000 | 1,442,800 | 20,000 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | Director | Option Exercise | A | 72.14 | 20,000 | 1,442,800 | 20,000 | |
| Jun 03 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | A | 72.14 | 20,000 | 1,442,800 | 20,000 |